← back to search

Gabriel Ozorowski

Scripps Institution of Oceanography · US
Area of research
Virology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Antibody, Virology, Epitope, Biology, Trimer, and Neutralizing antibody.
h-index
citations
7,266
works
60
NIH funding
primary concept
email

Recent publications

Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Science 2025cited by 51position: middledoi
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science 2025cited by 35position: middledoi
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial
Science Translational Medicine 2025cited by 23position: middledoi
Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion
Science Translational Medicine 2025cited by 13position: middledoi
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models
Science Translational Medicine 2025cited by 12position: middledoi
HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates
Science Immunology 2025cited by 8position: middledoi
Microfluidics combined with electron microscopy for rapid and high-throughput mapping of antibody–viral glycoprotein complexes
Nature Biomedical Engineering 2025cited by 7position: middledoi
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer
Immunity 2025cited by 4position: middledoi
Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques
Immunity 2025cited by 3position: middledoi
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis
npj Vaccines 2025cited by 1position: middledoi
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies
Science 2024cited by 63position: middledoi
Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates
Science 2024cited by 61position: middledoi
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Nature Immunology 2024cited by 50position: middledoi
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
Science Immunology 2024cited by 36position: middledoi
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
The Journal of Experimental Medicine 2024cited by 26position: middledoi
Immunization with germ line–targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques
Science Immunology 2024cited by 20position: middledoi
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
Cell Reports Medicine 2023cited by 50position: middledoi
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates
Nature Communications 2023cited by 24position: middledoi
Author Correction: Long-primed germinal centres with enduring affinity maturation and clonal migration
Nature 2023cited by 16position: middledoi
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Journal of Clinical Investigation 2023cited by 14position: middledoi
Long-primed germinal centres with enduring affinity maturation and clonal migration
Nature 2022cited by 188position: middledoi
From structure to sequence: Antibody discovery using cryoEM
Science Advances 2022cited by 49position: middledoi
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
Nature Communications 2022cited by 44position: middledoi
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus
Nature Communications 2022cited by 10position: middledoi
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
Cell Reports 2021cited by 127position: middledoi
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Cell Reports 2021cited by 66position: middledoi
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
PLoS Pathogens 2020cited by 91position: middledoi
Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
Journal of Virology 2020cited by 84position: middledoi
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
Science 2019cited by 279position: middledoi
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
Nature Communications 2019cited by 154position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew B. Ward · Scripps (United States)23 papers (2015–2025)Rogier W. Sanders · Scripps Research Institute18 papers (2015–2022)John P. Moore · Cornell University16 papers (2015–2021)Ian A. Wilson · Raigmore Hospital14 papers (2015–2020)Per Johan Klasse · Cornell University13 papers (2015–2021)Albert Cupo · Cornell University12 papers (2015–2021)Christopher A. Cottrell · Scripps Research Institute10 papers (2015–2022)Dennis R. Burton · Scripps Research Institute9 papers (2015–2025)Max Crispin · Duke Medical Center8 papers (2015–2022)Marit J. van Gils · Amsterdam University Medical Centers8 papers (2015–2022)Thomas J. Ketas · Cornell University8 papers (2015–2019)Anila Yasmeen · Cornell University8 papers (2015–2021)Rajesh P. Ringe · Institute of Microbial Technology8 papers (2015–2019)Celia C. LaBranche · Duke Medical Center6 papers (2015–2019)David C. Montefiori · Duke University6 papers (2015–2019)Kwinten Sliepen · Netherlands Institute for Neuroscience6 papers (2015–2022)Pavel Pugach · Cornell University6 papers (2015–2018)Steven W. de Taeye · Amsterdam University Medical Centers5 papers (2015–2021) · 4 papers (2015–2021)William R. Schief · Scripps Research Institute4 papers (2016–2025)